Author

I. S. Lacroix

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Banerjee· 1 shared A. D'Alessandro· 1 shared A. L. Cralley· 1 shared C. B. Erickson· 1 shared C. C. Silliman· 1 shared D. R. Pattabiraman· 1 shared E. E. Moore· 1 shared F. W. Kolling· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Banerjee

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Trans-Omics analysis of post injury thrombo-inflammation identifies endotypes and trajectories in trauma patients.

M. J. Cohen, C. B. Erickson, I. S. Lacroix, M. Debot, M. Dzieciatkowska, T. R. Schaid, M. W. Hallas, O. N. Thielen, A. L. Cralley, A. Banerjee, E. E. Moore, C. C. Silliman, A. D'Alessandro, K. C. Hansen

Trans-omics analysis of longitudinal plasma samples from severely injured patients identifies endotypes and trajectories that predict clinical outcomes.

bioRxiv · Aug 16, 2023 · PreprintBiochemistry

Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression

M. Bagheri, G. A. Mohamed, M. A. Mohamed Saleem, N. B. Ognjenovic, H. Lu, F. W. Kolling, O. M. Wilkins, S. Das, I. S. LaCroix, S. H. Nagaraj, K. E. Muller, S. A. Gerber, T. W. Miller, D. R. Pattabiraman

The paper shows that eribulin induces MET in mesenchymal-like TNBC cells, reducing metastatic potential and increasing sensitivity to other chemotherapeutics.

bioRxiv · Apr 19, 2023 · PreprintCancer Biology